Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 15Etoposide 13atezolizumab 9Topotecan 8durvalumab 7Specimen Handling 7PM 01183 6Cisplatin 5pembrolizumab 4Magnetic Resonance Spectroscopy 4Irinotecan 4Injections 3Biopsy 3berzosertib 2Nivolumab 2Fulvestrant 2Drug Therapy 2AMG 757 2tremelimumab 1trastuzumab deruxtecan 1toripalimab 1tazemetostat 1palbociclib 1olaparib 1lenvatinib 1fludarabine 1enzalutamide 1cabozantinib 1budigalimab 1arginine decarboxylase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Small Cell Lung Carcinoma × Dihematoporphyrin Ether × 30 days × Clear all
NCT03735095 2026-05-14

Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer

Roswell Park Cancer Institute

Phase 1/2 Completed
19 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡